Literature DB >> 28418084

Epstein-Barr virus infection induces genome-wide de novo DNA methylation in non-neoplastic gastric epithelial cells.

Keisuke Matsusaka1, Sayaka Funata1,2, Masaki Fukuyo1, Yasuyuki Seto3, Hiroyuki Aburatani4, Masashi Fukayama2, Atsushi Kaneda1.   

Abstract

Epstein-Barr virus (EBV)-positive gastric cancer (GC) shows a higher DNA methylation epigenotype. EBV infection can causally induce genome-wide aberrant DNA methylation, as previously demonstrated by in vitro infection experiments in the low-methylation GC cell line MKN7. However, whether EBV exerts DNA methylation remodelling properties in non-neoplastic epithelial cells remains unclear. Here we performed post-infection time-series DNA methylation analyses using the immortalized normal gastric epithelial cell line GES1. Genome-wide analysis using Illumina's Infinium 450 k BeadArray demonstrated global de novo DNA methylation from post-infection day 17, which was completed by 28 days in a manner similar to that observed in MKN7 cells. De novo methylation of all types of GC-specific methylation marker genes was observed, indicating that EBV infection is sufficient for gastric epithelial cells to acquire an EBV-positive GC epigenotype. Pyrosequencing demonstrated that methylation of the viral genome preceded that of the host cellular genome, suggesting the existence of well-ordered mechanisms that induce methylation. Spatiotemporal representation with differential models revealed dynamic alterations of DNA methylation in promoter regions, occurring from lower-CpG peripheral regions and extending to higher-CpG core regions. In summary, EBV infection exerted powerful pressure to induce global de novo DNA methylation in non-neoplastic cells within a month in a spatiotemporally well-ordered manner.
Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  Epstein-Barr virus; de novo DNA methylation; gastric cancer; non-neoplastic epithelial cells

Mesh:

Year:  2017        PMID: 28418084     DOI: 10.1002/path.4909

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

Review 1.  Phylogenetic comparison of Epstein-Barr virus genomes.

Authors:  Su Jin Choi; Seok Won Jung; Sora Huh; Hyosun Cho; Hyojeung Kang
Journal:  J Microbiol       Date:  2018-06-14       Impact factor: 3.422

Review 2.  Thirty years of Epstein-Barr virus-associated gastric carcinoma.

Authors:  Masashi Fukayama; Hiroyuki Abe; Akiko Kunita; Aya Shinozaki-Ushiku; Keisuke Matsusaka; Tetsuo Ushiku; Atsushi Kaneda
Journal:  Virchows Arch       Date:  2019-12-13       Impact factor: 4.064

Review 3.  The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.

Authors:  Jun Nishikawa; Hisashi Iizasa; Hironori Yoshiyama; Munetaka Nakamura; Mari Saito; Sho Sasaki; Kanami Shimokuri; Masashi Yanagihara; Kouhei Sakai; Yutaka Suehiro; Takahiro Yamasaki; Isao Sakaida
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

Review 4.  Clinical Importance of Epstein⁻Barr Virus-Associated Gastric Cancer.

Authors:  Jun Nishikawa; Hisashi Iizasa; Hironori Yoshiyama; Kanami Shimokuri; Yuki Kobayashi; Sho Sasaki; Munetaka Nakamura; Hideo Yanai; Kohei Sakai; Yutaka Suehiro; Takahiro Yamasaki; Isao Sakaida
Journal:  Cancers (Basel)       Date:  2018-05-29       Impact factor: 6.639

5.  Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein-Barr virus-associated gastric cancer.

Authors:  Hirofumi Ohmura; Mamoru Ito; Keita Uchino; Chihiro Okada; Shigeki Tanishima; Yuichi Yamada; Seiya Momosaki; Masato Komoda; Miyuki Kuwayama; Kyoko Yamaguchi; Yuta Okumura; Michitaka Nakano; Kenji Tsuchihashi; Taichi Isobe; Hiroshi Ariyama; Hitoshi Kusaba; Yoshinao Oda; Koichi Akashi; Eishi Baba
Journal:  FEBS Open Bio       Date:  2019-12-03       Impact factor: 2.693

Review 6.  Could Changing the DNA Methylation Landscape Promote the Destruction of Epstein-Barr Virus-Associated Cancers?

Authors:  Alison J Sinclair
Journal:  Front Cell Infect Microbiol       Date:  2021-05-28       Impact factor: 5.293

7.  Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.

Authors:  Huang Kie Kyon; Arnoud Boot; Nisha Padmanabhan; Kevin Lim; Supriya Srivastava; Shuwen Chen; Zhiyuan Wu; Hyung-Ok Lee; Vineeth T Mukundan; Charlene Chan; Yarn Kit Chan; Ong Xuewen; Jason J Pitt; Zul Fazreen Adam Isa; Manjie Xing; Ming Hui Lee; Angie Lay Keng Tan; Shamaine Ho Wei Ting; Micah A Luftig; Dennis Kappei; Warren D Kruger; Jinsong Bian; Ying Swan Ho; Ming Teh; Steve George Rozen; Patrick Tan
Journal:  Genome Biol       Date:  2021-06-01       Impact factor: 13.583

8.  Histone modification alteration coordinated with acquisition of promoter DNA methylation during Epstein-Barr virus infection.

Authors:  Sayaka Funata; Keisuke Matsusaka; Ryota Yamanaka; Shogo Yamamoto; Atsushi Okabe; Masaki Fukuyo; Hiroyuki Aburatani; Masashi Fukayama; Atsushi Kaneda
Journal:  Oncotarget       Date:  2017-07-21

9.  Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3.

Authors:  Yuta Asakawa; Atsushi Okabe; Masaki Fukuyo; Wenzhe Li; Eriko Ikeda; Yasunobu Mano; Sayaka Funata; Hiroe Namba; Takahiro Fujii; Kazuko Kita; Keisuke Matsusaka; Atsushi Kaneda
Journal:  Cancer Sci       Date:  2020-03-20       Impact factor: 6.716

10.  Profiling of immune related genes silenced in EBV-positive gastric carcinoma identified novel restriction factors of human gammaherpesviruses.

Authors:  Guillaume N Fiches; Dawei Zhou; Weili Kong; Ayan Biswas; Elshafa H Ahmed; Robert A Baiocchi; Jian Zhu; Netty Santoso
Journal:  PLoS Pathog       Date:  2020-08-25       Impact factor: 7.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.